Our Focus
The Idaho Chapter of the National Bleeding Disorders Foundation provides education, support, awareness, and advocacy for our bleeding disorder community. We are the leading resource for those affected by bleeding disorders in the state of Idaho. You can count on us to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.
Our Mission ... In Action
-
We provide year-round events and fundraisers to spread awareness, educate, and generate crucial resources in support of our mission. Hope to see you at our next event!
-
We fight to protect access to quality healthcare and treatments we need to live healthy lives, but we can't do it without your voice. Discover how you and your family can make a big difference by joining our advocacy efforts.
-
We provide mission-focused experiences through education, support, community connections, and fun for those affected by bleeding disorders.
News Articles
The National Bleeding Disorders Foundation (NBDF) announced the official creation of Guam Chapter of the National Bleeding Disorders Foundation.
Advocacy efforts led by the National Bleeding Disorders Foundation (NBDF), in collaboration with the Glanzmann’s Research Foundation and the CHES Foundation, have resulted in a dedicated ICD-10-CM code for Glanzmann thrombasthenia, a rare inherited platelet disorder. The new code, D69.11, will help clinicians, researchers, insurance companies, and public health systems identify Glanzmann thrombasthenia more accurately and better understand the needs of people living with the disorder.
The National Bleeding Disorders Foundation (NBDF) has announced the 2026 recipients of its Judith Graham Pool (JGP) Fellowships. This year's awardees are investigating next-generation hemophilia A gene therapy and hereditary hemorrhagic telangiectasia (HHT), a rare inherited bleeding disorder caused by abnormal blood vessel development. The fellowships fund early-career researchers investigating the causes and treatment of bleeding disorders through basic science and pre-clinical research.
